Related Experiment Video
Updated: Jul 24, 2026

06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
β-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells
Lina Sui1, Nichole Danzl2, Sean R Campbell2
1Naomi Berrie Diabetes Center and Department of Pediatrics, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY.
Diabetes
|September 22, 2017
Summary
Nuclear transfer embryonic stem cells (NT-ESs) from type 1 diabetes patients can become functional beta-cells. These cells successfully restore normal blood glucose levels after transplantation, offering hope for diabetes cell therapy.
Area of Science:
- Stem cell biology
- Endocrinology
- Regenerative medicine
Background:
- Stem cell-derived beta-cells are promising for diabetes treatment.
- Autologous cell replacement therapy aims to avoid immune rejection.
Purpose of the Study:
- To assess the potential of nuclear transfer embryonic stem cells (NT-ESs) from type 1 diabetes patients for autologous beta-cell replacement.
- To evaluate the differentiation capacity and in vivo function of NT-ES-derived beta-cells.
Main Methods:
- NT-ESs were differentiated in vitro into C-peptide-positive cells.
- Differentiated cells were analyzed for mature beta-cell markers (MAFA, NKX6.1).
- Cells were transplanted into immunodeficient mice, and their function was assessed after endogenous beta-cell ablation.
Main Results:
- NT-ESs differentiated into beta-cells with 55% efficiency, expressing mature markers.
- Transplanted cells formed vascularized islet-like structures and adapted insulin secretion.
- NT-ES-derived beta-cells normalized blood glucose levels in mice.
- No teratomas were observed, only cystic structures.
Conclusions:
- NT-ES-derived beta-cells are suitable for type 1 diabetes cell replacement therapy.
- This study provides proof of principle for therapeutic cloning combined with cell therapy for diabetes.
Related Concept Videos
Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

